Professional Documents
Culture Documents
Final Draft-Muna 1
Final Draft-Muna 1
Final Draft-Muna 1
entirely to permanently avoid overdosing patients during treatment2. The emergence of imaging
has become an invaluable tool to enhance the precision of each treatment. Various imaging
techniques such as image-guided radiation therapy (IGRT) allow for patient position to be
verified before treatment, while others, like portal imaging, confirm not only patient alignment
but the actual treatment field2. More sophisticated programs allowed for constant imaging during
treatment to detect any deviation known as intra-fractional monitoring (IMR)2. Lastly, adaptive
planning based on the current Cone Beam Computer Tomography(CBCT) taken of the patient
can be implemented to ensure any internal variation is addressed before treatment2.
Despite the rare occurrence of catastrophic events sensationalized by the media, the
public concern for the safety of radiation oncology continues. The rigorous testing of the
mechanical aspect of radiation oncology is only the first step in intra-disciplinary quality
assurance and risk-reducing strategies implemented by radiation oncology3. In a publication by
Terezakis SA et al, an internal review reported an error rate of 0.4%( 17 out of 4227 patients)
which encouraged further improvement of established workflows 3. This publication advocates
for a nationwide safety initiative, advocating for the creation of a standardized radiation
oncology workflow. Additionally, Terezakis SA et al propose and implement a voluntary
intradepartmental error and near-miss reporting system 3. These measures inherently aim to
improve safety standards within the radiation oncology department.
Terezakis SA et al article delves into enhancing professional training by proposing a
national voluntary error reporting system to collect errors and near misses3. While many
departments have institutional-based reporting systems to improve clinical workflow and the
safety of patients, a national database can allow smaller clinics to identify common errors and
apply them to their departmental training. Furthermore, Terezakis SA et al advocates for a
standardized definition of error and near miss across radiation oncology departments to establish
a universal language for better communication3.
This study identifies a total of 270 steps taken in a radiation oncology department from
simulation to treatment and has marked a substantially low error rate, with many steps being
nearly 99.9% error-proof3. This can be attributed to not only the mechanical and treatment
planning QA, but also weekly intra-professional peer review conferences, verification of patient
setup utilizing both inter and intrafraction monitors, and radiation dose checks utilizing diode3.
3
Moreover, emerging strategies now being explored and implemented by many radiation
oncology departments include utilizing failure mode and effects analysis (FEMA) which takes a
proactive approach to identify any errors that can occur in radiation oncology3. When each error
that could occur is identified, a risk reduction is implemented to intervene in any errors identified
by the FEMA analysis3. The article emphasizes deleting unused CT scans and correctly labeling
CT scans, double and cross-checking the correct plan is moded up, exporting correct verification
images, and photographing patients' marks for reference during setup3. Each area highlighted
above serves as a reminder of improvements that each radiation oncology strives to achieve by
implementing an institution standard labeling system, physician-approved CT scans being
imported to planning systems, barcodes as part of patient identity verification, and a
computerized record and verification system.
Radiation oncology's ongoing commitment to identifying errors and reducing
uncertainties creates a transparent environment that actively cultivates trust between
professionals and the general public. The rare but impactful catastrophic events witnessed by the
public serve as a reminder of the potential risks when proper precautions aren't followed. The
commission of technological advancements in radiation oncology strives to limit uncertainties in
patient treatment to below 5% for each patient in our care2. Furthermore, the thorough dedication
of each professional in quality assurance programs, continual training, and federal laws allows us
to optimize patient care while reducing risk. Overall, the oversight amplifies the commitment to
ensure public safety.
4
Citation:
2. Palta JR, Liu C, Li JG. Quality assurance of intensity-modulated radiation therapy. Int J
Radiat Oncol Biol Phys. 2008;71(1 Suppl):S108-S112. Accessed December 3, 2023,
doi:10.1016/j.ijrobp.2007.05.092